You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atezolizumab

Showing 1 - 25 of 400
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma Trial (Atezolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • Atezolizumab
  • (no location specified)
Oct 3, 2023

Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)

Completed
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Atezolizumab
  • +2 more
  • Athens, Greece
  • +1 more
Sep 16, 2023

Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • all trans Retinoic Acid
  • +2 more
  • (no location specified)
Aug 11, 2023

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • NSCLC
  • (no location specified)
Apr 5, 2023

Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Atezolizumab
  • +2 more
  • Taoyuan City, Taiwan
    Chang Gung Memorial Hospital at Linkou
Nov 17, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

Not yet recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Sep 1, 2023

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Hepatocellular Carcinoma Trial (Ezurpimtrostat, Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Grenoble, France
    University Hospital
Dec 23, 2022

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Atezolizumab
  • +3 more
  • (no location specified)
Jun 14, 2023

Stage II Melanoma Trial in United States (Atezolizumab, Tiragolumab, Signatera Assay)

Recruiting
  • Stage II Melanoma
  • Atezolizumab
  • +2 more
  • Duarte, California
  • +5 more
Nov 10, 2022

Endometrial Cancer, Metastasis Trial (Atezolizumab, ONC201)

Not yet recruiting
  • Endometrial Cancer
  • Metastasis
  • (no location specified)
Sep 12, 2022

Hepatocellular Carcinoma Trial (NP137, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Sep 23, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Atezolizumab
  • Essen, Germany
    University Hospital Essen
Nov 2, 2022

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
Dec 13, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Abemaciclib, Atezolizumab)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 26, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Oct 25, 2023

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

Not yet recruiting
  • Locally Advanced Solid Tumors
  • +2 more
  • (no location specified)
Sep 4, 2023

Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Atezolizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Aug 23, 2022

Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 18, 2023

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Atezolizumab
  • +2 more
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

Not yet recruiting
  • Solid Tumor
  • Atezolizumab
  • +3 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Aug 30, 2022

Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))

Active, not recruiting
  • Breast Cancer
  • Atezolizumab
  • Stereotactic radiosurgery (SRS)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 15, 2022